COMMUNIQUÉS West-GlobeNewswire

Rule 2.9 Announcement
18/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 October 2018 [...]
Enzymatica AB: Enzymatica signs agreement for the Japanese market
18/10/2018
Press release October 18, 2018 Enzymatica signs agreement for the Japanese market Enzymatica has entered into an agreement with a large Japanese pharmaceutical company regarding registration, marketing, distribution and [...]
Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion
18/10/2018
Novartis to acquire Endocyte for $24 per fully diluted share in cash PSMA-617 to enhance Novartis’ industry-leading radio-ligand therapy platform WEST LAFAYETTE, Ind., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. ( [...]
Novartis announces planned acquisition of Endocyte to expand expertise in radiopharmaceuticals and build on commitment to transformational therapeutic platforms
18/10/2018
Novartis to acquire Endocyte to accelerate development of innovative radioligand technology for treating cancer Acquisition would add 177 Lu-PSMA-617 , a potential first-in-class radioligand therapy in Phase III [...]
Novartis delivered strong growth and innovation during the third quarter, including progressing advanced therapy platforms to drive future growth
18/10/2018
Net sales grew 6% (cc[1], +3% USD) mainly driven by: Cosentyx grew to USD 750 million (+37% cc) with strong volume growth across indications Entresto more than doubled to USD 271 million (+113% cc) driven by continued [...]
Novartis a enregistré, au troisième trimestre, une forte croissance et fait preuve d'une innovation dynamique, incluant des plateformes thérapeutiques avancées pour soutenir la croissance future
18/10/2018
Hausse du chiffre d'affaires net de 6% (tcc[1], +3% USD), stimulée principalement par: Cosentyx , qui a progressé à USD 750 millions (+37% tcc) grâce à une forte croissance en volume dans toutes ses indications Entresto [...]
Aclaris Announces Pricing of Public Offering of Common Stock
18/10/2018
WAYNE, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering
18/10/2018
BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the pricing of its initial public offering of 6,650,000 ordinary shares at [...]
Abattis Bioceuticals Celebrates Legalization
18/10/2018
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a [...]
PhaseBio Announces Pricing of Initial Public Offering
18/10/2018
MALVERN, Pa. and SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (“PhaseBio”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Meridian Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on November 8, 2018
17/10/2018
CINCINNATI, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report fourth quarter and full year 2018 financial [...]
Kane Biotech Announces New Manufacturing Partner for bluestem™ Product Line
17/10/2018
Strategic Partnership Reduces Annual Overhead Costs by More than C$200,000 WINNIPEG, Manitoba, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) , today [...]
Globus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
17/10/2018
AUDUBON, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association [...]
IntelGenx Announces Proposed Equity Offering
17/10/2018
SAINT LAURENT,, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) today announced that it intends to distribute units (the “ Units ”), each Unit [...]
OpGen Announces Proposed Public Offering of Common Stock
17/10/2018
GAITHERSBURG, Md., Oct. 17, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that it has commenced an underwritten public offering of its common stock. All of the shares are being offered by OpGen, [...]
Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors
17/10/2018
MENLO PARK, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Marrone Bio Innovations Appoints Barner Jones as New Director of National Sales and Account Management
17/10/2018
DAVIS, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Barner Jones [...]
Inspire Medical Systems, Inc. Announces Presentation of Clinical Efficacy Data for Inspire Therapy for Treatment of Obstructive Sleep Apnea at Annual ENT Surgeon Conference
17/10/2018
Data Includes Treatment Effect of Inspire Therapy in Medicare-aged Population Compared with Younger Patients MINNEAPOLIS, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a [...]
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
17/10/2018
PITTSBURGH, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from [...]

Pages